• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺增生导致的死亡率下降:一项未被大肆宣扬的重大健康成就。

Decrease in mortality from benign prostatic hyperplasia: a major unheralded health triumph.

作者信息

Boyle P, Maisonneuve P, Steg A

机构信息

Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.

出版信息

J Urol. 1996 Jan;155(1):176-80.

PMID:7490826
Abstract

PURPOSE

A systematic examination of all available mortality data from benign prostatic hyperplasia (BPH) between 1950 and 1990 was done to estimate the changing international mortality pattern of this condition.

MATERIALS AND METHODS

Mortality data in which BPH was the underlying cause of death were abstracted from the World Health Organization mortality data base. These data were available from a variety of international countries (in many since 1950).

RESULTS

Mortality rates have decreased with considerable magnitude in developed western countries between the early 1950s and late 1980s. This fact could reasonably be attributed to the improved management of the most severe complications of BPH and to improvements in surgery and anesthesia, which have made surgical interventions of the prostate possible in a greater proportion of men, and safer in the immediate and subsequent postoperative period.

CONCLUSIONS

The decreases noted in western countries, such as the United Kingdom (where 8,700 fewer men die each year presently than would be expected if the BPH mortality rates from the early 1950s still applied), United States (13,681 fewer deaths) and France (2,884 fewer deaths), indicate a considerable but unheralded achievement for modern medicine. Unfortunately, these decreases have not been observed to the same extent in central and eastern Europe and South America, where the residual high mortality rates could be lowered by education, and the widespread availability of modern surgical and anesthetic equipment.

摘要

目的

对1950年至1990年间所有可获得的良性前列腺增生(BPH)死亡率数据进行系统审查,以估计这种疾病在国际上不断变化的死亡率模式。

材料与方法

从世界卫生组织死亡率数据库中提取以BPH为根本死因的死亡率数据。这些数据来自多个国家(许多国家自1950年起就有数据)。

结果

在20世纪50年代初至80年代末期间,西方发达国家的死亡率有相当大幅度的下降。这一事实合理地归因于BPH最严重并发症管理的改善以及手术和麻醉技术的进步,这使得更大比例的男性能够接受前列腺手术,并且在手术即刻及术后更安全。

结论

在西方国家观察到的死亡率下降情况,如英国(目前每年死于BPH的男性比如果仍采用20世纪50年代初的死亡率预期少8700人)、美国(少13681人死亡)和法国(少2884人死亡),表明现代医学取得了一项相当可观但未被广泛宣扬的成就。不幸的是,在中欧、东欧和南美洲并未观察到同样程度的下降,在这些地区,通过教育以及广泛提供现代手术和麻醉设备,可以降低仍然较高的死亡率。

相似文献

1
Decrease in mortality from benign prostatic hyperplasia: a major unheralded health triumph.良性前列腺增生导致的死亡率下降:一项未被大肆宣扬的重大健康成就。
J Urol. 1996 Jan;155(1):176-80.
2
Recent trends in mortality from benign prostatic hyperplasia.良性前列腺增生症死亡率的近期趋势。
Prostate. 2003 Aug 1;56(3):207-11. doi: 10.1002/pros.10250.
3
Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.良性前列腺增生导致的死亡率:1950 - 1992年全球趋势
J Epidemiol Community Health. 1995 Aug;49(4):379-84. doi: 10.1136/jech.49.4.379.
4
New insights into the epidemiology and natural history of benign prostatic hyperplasia.良性前列腺增生症流行病学及自然史的新见解
Prog Clin Biol Res. 1994;386:3-18.
5
Mortality trends for benign prostatic hyperplasia and prostate cancer in English populations 1979-2006.1979-2006 年英国人群中良性前列腺增生和前列腺癌的死亡率趋势。
BJU Int. 2011 Jan;107(1):40-5. doi: 10.1111/j.1464-410X.2010.09487.x.
6
Alcohol accounts for a high proportion of premature mortality in central and eastern Europe.在中东欧地区,酒精导致的过早死亡率占比很高。
Int J Epidemiol. 2007 Apr;36(2):458-67. doi: 10.1093/ije/dyl294. Epub 2007 Jan 24.
7
Eastern Europe: pronatalist policies and private behavior.东欧:鼓励生育政策与个人行为
Popul Bull. 1982 Feb;36(6):1-49.
8
Urologic diseases in America project: benign prostatic hyperplasia.美国泌尿系统疾病项目:良性前列腺增生
J Urol. 2005 Apr;173(4):1256-61. doi: 10.1097/01.ju.0000155709.37840.fe.
9
A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.一项比较经尿道前列腺切除术、接触式激光前列腺切除术和经尿道前列腺电汽化术治疗良性前列腺增生症患者的随机对照试验:主观变化、发病率和死亡率分析
J Urol. 2003 Apr;169(4):1411-6. doi: 10.1097/01.ju.0000054657.59200.97.
10
Leveling of prostate cancer mortality in Western Europe.西欧前列腺癌死亡率的平稳态势。
Prostate. 2004 Jun 15;60(1):46-52. doi: 10.1002/pros.20058.

引用本文的文献

1
The role of international partnerships in improving urethral reconstruction in low- and middle-income countries.国际合作在改善中低收入国家尿道重建中的作用。
World J Urol. 2020 Dec;38(12):3003-3011. doi: 10.1007/s00345-019-02819-2. Epub 2019 Jun 8.
2
Prevalence estimates for lower urinary tract symptom severity among men in Uganda and sub-Saharan Africa based on regional prevalence data.基于区域患病率数据对乌干达及撒哈拉以南非洲男性下尿路症状严重程度的患病率估计。
Can Urol Assoc J. 2018 Nov;12(11):E447-E452. doi: 10.5489/cuaj.5105. Epub 2018 Jun 8.
3
Global implementation of advanced urological care: Policy implementation research.
先进泌尿外科护理的全球实施:政策实施研究。
Can Urol Assoc J. 2017 Jun;11(6):157-160. doi: 10.5489/cuaj.4117.
4
Associations between the severity of obstructive lower urinary tract symptoms and care-seeking behavior in rural Africa: A cross-sectional survey from Uganda.非洲农村地区下尿路梗阻症状严重程度与就医行为之间的关联:来自乌干达的一项横断面调查。
PLoS One. 2017 Mar 16;12(3):e0173631. doi: 10.1371/journal.pone.0173631. eCollection 2017.
5
An Analytical Study of Prostate-Specific Antigen Dynamics.前列腺特异性抗原动力学的分析研究
Comput Math Methods Med. 2016;2016:3929163. doi: 10.1155/2016/3929163. Epub 2016 Nov 13.
6
Drug treatments for lower urinary tract symptoms secondary to bladder outflow obstruction: focus on quality of life.膀胱流出道梗阻继发下尿路症状的药物治疗:关注生活质量。
Drugs. 2003;63(18):1947-62. doi: 10.2165/00003495-200363180-00004.
7
Early treatment of benign prostatic hyperplasia: implications for reducing the risk of permanent bladder damage.良性前列腺增生的早期治疗:对降低永久性膀胱损伤风险的意义。
Drugs Aging. 2003;20(3):185-95. doi: 10.2165/00002512-200320030-00003.
8
Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.良性前列腺增生的治疗:药物经济学视角
Drugs Aging. 1997 Feb;10(2):107-18. doi: 10.2165/00002512-199710020-00004.